SigmaCare has secured new equity funding from healthcare investment firm Marlin Equity Partners and existing investors. SigmaCare provides clinical software to the long-term and post-acute care market enabling providers to improve quality of care and financial results by driving down costs, increasing revenue and reducing risk and re-hospitalisations.
Green Innovations has settled over USD2.6m in trade payables, removing these obligations from its balance sheet, in exchange for the issuance of shares of its common stock to Ironridge Consumer Co, an institutional investor specialising in direct equity investments in consumer product companies. As a result of the transaction,
Venture capital fund manager Mercia Fund Management (MFM) has invested GBP150,000 in Oxford Genetics Ltd. The new biotechnology company is behind SnapFast – a system that simplifies the purchase of synthetic DNA molecules (plasmids). Dr Ryan Cawood, chief executive of Oxford Genetics, invented the SnapFast system and likens
A fifth portfolio company of life sciences venture capital firm Domain Associates has received funding under its investment agreement with Russian state investment corporation Rusnano. ReVision Optics, a Southern California-based firm developing Raindrop, an inlay for presbyopic vision correction in Phase III trials, has raised USD55m in a financing
Venture capital investment into European companies experienced a quarter over quarter increase, while exits for European venture-backed companies improved on Q1 2013. However, during the first half of 2013, initial public offering (IPO) and merger and acquisition (M&A) activity declined in contrast to the same period in 2012.
Darwin Private Equity has completed the management buyout of Esendex, a provider of mission-critical application-to-person SMS services to businesses, in a deal worth GBP11m. Esendex’s services are used by more than 6,500 businesses around the world to improve customer service, communicate with employees, increase operational efficiency and generate sales.
New Zealand private equity investor Rangatira has acquired a 12 per cent stake in benchtop NMR and MRI specialist Magritek for a non-disclosed sum. The transaction will strengthen Magritek’s balance sheet and enable the company to make a significant investment in its offshore sales and marketing following the launch
Precision Engineered Technologies, a portfolio company of private equity firm Joshua Partners, has acquired Imperial Machine and Tool Company, a precision boring and machining company based in Wadsworth, Ohio near Akron. Charles Corpening, the chairman and founder of Joshua Partners, says: "The team at Imperial has built the company
Mercia Fund Management (MFM) portfolio company PolyTherics has merged with Antitope, a provider of antibody engineering and immunogenicity screening services, to create an enlarged group with an extensive suite of services and technologies to enable the development of better biopharmaceuticals. PolyTherics is issuing new shares up to an aggregate
NewSpring Capital has led a USD15.65m equity financing in VidSys, a provider of physical security information management (PSIM) software. NewSpring Capital, a family of private equity funds, invested through NewSpring Growth Capital, the firm’s dedicated technology and business services growth equity fund. Also participating were VidSys’ existing investors –
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
